Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ColoSense Post Approval Study

NCT07069556 is registered in ClinicalTrials.gov with Geneoscopy, Inc. as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07069556 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ColoSense Post Approval Study
Lead sponsor
Geneoscopy, Inc.
Phase
Observational
Overall status
Recruiting
Start date
September 5, 2025
Completion date
September 1, 2030
Enrollment
12,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer (diagnosis)